Mitochondrial DNA in somatic cells: A promising target of routine clinical tests

Dongchon Kang, Naotaka Hamasaki

研究成果: Contribution to journalReview article査読

8 被引用数 (Scopus)

抄録

Alterations of mitochondrial DNA have long been considered only from a point of view of rare genetic disorders causing neuromyopathy. Recently, alterations of mitochondrial DNA have been found in so-called common diseases such as heart failure, diabetes, and cancer; some of these alterations are inherited, and some are generated and/or accumulated in somatic cells with age. Mitochondrial DNA is more vulnerable to alteration than is nuclear DNA. For example, mitochondria produce a large amount of reactive oxygen species as an inevitable byproduct of oxidative phosphorylation. Therefore, mitochondrial DNA is under much stronger oxidative stress than is nuclear DNA. In spite of the importance, it is much less elucidated in the mitochondrial genome than in the nuclear genome how the genome is maintained. In this review, we focus on maintenance of mitochondrial DNA in somatic cells and its clinical importance.

本文言語英語
ページ(範囲)685-695
ページ数11
ジャーナルClinical Biochemistry
38
8
DOI
出版ステータス出版済み - 8 1 2005

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

フィンガープリント 「Mitochondrial DNA in somatic cells: A promising target of routine clinical tests」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル